Over 35,000 donors rally to support infant’s urgent gene therapy journey
A wave of generosity has helped a young family secure a life-changing treatment for their five-month-old baby diagnosed with a rare genetic disease.
Community Rallies Behind Urgent Cause
A crowdfunding campaign for baby Ginny has successfully raised over $2.4 million, with support from more than 35,000 donors. The overwhelming response highlights the power of community action in times of urgent medical need.
Her parents expressed deep gratitude, sharing that the generosity of strangers has given their daughter a fighting chance at life.
Race Against Time for Treatment
Ginny has been diagnosed with Spinal Muscular Atrophy (SMA), a severe genetic condition that progressively weakens muscles and affects vital functions. Without treatment, her life expectancy is estimated to be under two years.
The funds will go towards Zolgensma, a one-time gene therapy that offers hope but comes with a hefty price tag and is not covered by insurance or subsidies.
Next Steps Before Treatment
Before receiving the therapy, Ginny must undergo a series of medical tests scheduled in the coming week. These assessments will determine if she is eligible to proceed with the treatment.
If cleared, the medication will be ordered and imported, a process expected to take at least two to three weeks.
Ongoing Care and Support
While waiting, Ginny has been receiving oral medication and physiotherapy to help slow the progression of the disease. These interim treatments are crucial in managing symptoms and maintaining her condition.
Doctors note that early intervention is key, especially for Type 1 SMA, which typically presents within the first six months of life.
Understanding the Severity of SMA
Type 1 SMA is the most common and severe form of the condition, often leading to difficulties in movement, feeding, and breathing. Patients typically experience weak muscle tone and frequent respiratory complications.
Medical experts emphasise that timely access to advanced therapies like Zolgensma can significantly improve outcomes and quality of life.
Baby Ginny’s story underscores both the challenges of accessing high-cost treatments and the extraordinary impact of collective compassion in changing a life’s trajectory.
Sources: Asia One (2026) , Shafaqna (2026)
Keywords: Baby Ginny SMA, Zolgensma Singapore, Crowdfunding Medical SG, SMA Treatment Cost, Rare Disease Support
